bf/NASDAQ:NBIX_icon.jpeg

NASDAQ:NBIX

Neurocrine Biosciences

  • Stock

USD

Last Close

154.80

06/11 21:01

Market Cap

14.81B

Beta: 0.49

Volume Today

1.00M

Avg: 705.73K

PE Ratio

72.61

PFCF: 36.18

OverviewFinancialsAPI

    Description

    Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatme...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -112342018-02-132020-02-042022-02-112024-02-052024-10-29

    Revenue (Estimate*)

    200M400M600M800M1B1.20B2018-02-132020-02-042022-02-112024-02-052024-10-29

    *Estimate based on analyst consensus